Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19

medRxiv(2020)10.1101/2020.07.20.20157503Source: DataRank Database

COVIDOSE: Low-dose tocilizumab in the treatment of Covid-19 is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (13)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Brian L. Heiss ORCID,Sherin J. Rouhani ORCID,Jonathan Trujillo ORCID,Jovian Yu ORCID,Alec Kacew ORCID

Live enrichment

PubMed:32743594 OpenAlex:https://openalex.org/W3044684614

NCI NIH HHS

Grant: K12 CA139160

NIGMS NIH HHS

Grant: T32 GM007019

NICHD NIH HHS

Grant: T32 HD007009

green

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/07/26/2020.07.20.20157503.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.07.20.20157503

repositoryhttps://doi.org/10.1101/2020.07.20.20157503

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32743594

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19

Keywords

TocilizumabMedicineInternal medicineRetrospective cohort studyGastroenterologyInterleukin 6C-reactive proteinMechanical ventilationDiseaseInflammation

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials

10.6084/m9.figshare.16880270.v1figshare

Additional file 1 of Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials

10.6084/m9.figshare.16880270figshare